|
UTP18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.370350E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.093400E-01 |
| Normal-vs-Stage2 |
5.347200E-01 |
| Normal-vs-Stage3 |
1.333980E-01 |
| Normal-vs-Stage4 |
1.096810E-01 |
| Stage1-vs-Stage2 |
8.265200E-01 |
| Stage1-vs-Stage3 |
4.550800E-01 |
| Stage1-vs-Stage4 |
2.533200E-01 |
| Stage2-vs-Stage3 |
4.380600E-01 |
| Stage2-vs-Stage4 |
1.741240E-01 |
| Stage3-vs-Stage4 |
5.395000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.750350E-02 |
| Normal-vs-AfricanAmerican |
4.007200E-01 |
| Normal-vs-Asian |
3.663200E-01 |
| Caucasian-vs-AfricanAmerican |
2.206600E-01 |
| Caucasian-vs-Asian |
6.356000E-01 |
| AfricanAmerican-vs-Asian |
2.896400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.287200E-01 |
| Normal-vs-Female |
8.33770000000511E-05 |
| Male-vs-Female |
7.816000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.898400E-01 |
| Normal-vs-Extreme_Weight |
2.168200E-01 |
| Normal-vs-Obese |
4.834500E-02 |
| Normal-vs-Extreme_Obese |
6.243400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.701000E-01 |
| Normal_Weight-vs-Obese |
3.577800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.296800E-01 |
| Extreme_Weight-vs-Obese |
4.708200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.440200E-01 |
| Obese-vs-Extreme_Obese |
1.807840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.338400E-03 |
| Normal-vs-Age(41-60Yrs) |
8.020700E-03 |
| Normal-vs-Age(61-80Yrs) |
3.276000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.584600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.764200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.982100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.324800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.054800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.587600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.687800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.380110E-02 |
| Normal-VS-Type2 PRCC |
6.648000E-01 |
| Normal-VS-KIRP CIMP |
1.684140E-03 |
| Normal-VS-Unclassified PRCC |
5.238600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.367780E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.836020E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.675400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.168960E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.118600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.599700E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.127800E-01 |
| Normal-vs-N1 |
1.273740E-02 |
| Normal-vs-N2 |
2.244800E-01 |
| N0-vs-N1 |
1.420010E-02 |
| N0-vs-N2 |
3.458300E-02 |
| N1-vs-N2 |
7.482200E-01 |
|
|
